
India needs to update its rules for biosimilars to ensure safe, effective, and affordable medicines
Biosimilars are highly similar, affordable versions of original biologic medicines, offering access for over two decades. They represent a significant leap in medical treatment, offering therapies for several diseases. While the initial biosimilar …